Analysis of mRNA Therapeutics and Vaccines
BioPharm Int.
; 35:10-15, 2022.
Article
in English
| EMBASE | ID: covidwho-1995149
protective equipment; endonuclease; lipid; lipid nanoparticle; messenger RNA; nanoparticle; polyadenylated RNA; RNA polymerase; SARS-CoV-2 vaccine; vaccine; capillary electrophoresis; cell membrane; chemistry; data processing; drug analysis; drug delivery system; drug development; drug impurity; drug screening; electron microscopy; electrophoresis; flow cytometry; high performance liquid chromatography; immunohistochemistry; liquid chromatography-mass spectrometry; manufacturing; mass spectrometry; microscopy; note; pharmaceutics; pharmacological parameters; polymerase chain reaction; process development; protein expression; quality control; RNA capping; RNA sequence; scale up; size exclusion chromatography; untranslated region
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Topics:
Vaccines
Language:
English
Journal:
BioPharm Int.
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS